These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37462369)

  • 1. Radiotherapy for postoperative vaginal recurrences of cervical squamous cell carcinoma: analysis of dosing and prognosis.
    Zheng Z; Hu K; Hou X; Yu L; Yan J; Zhang F
    J Obstet Gynaecol; 2023 Dec; 43(2):2213328. PubMed ID: 37462369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of salvage therapies for isolated para-aortic lymph node recurrence in patients with uterine cervical cancer after definitive treatment.
    Kubota H; Tsujino K; Sulaiman NS; Sekii S; Matsumoto Y; Ota Y; Soejima T; Yamaguchi S; Sasaki R
    Radiat Oncol; 2019 Dec; 14(1):236. PubMed ID: 31878944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of preoperative serum squamous cell carcinoma antigen (SCC-Ag) level on tumor recurrence in cervical squamous cell carcinoma patients treated with radical surgery: A single-institution study.
    Guo Q; Zhu J; Wu Y; Wen H; Xia L; Wu X; Ju X
    Eur J Surg Oncol; 2020 Jan; 46(1):131-138. PubMed ID: 31481274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy.
    Chen JL; Huang CY; Huang YS; Chen RJ; Wang CW; Chen YH; Cheng JC; Cheng AL; Kuo SH
    Acta Obstet Gynecol Scand; 2014 Jul; 93(7):661-8. PubMed ID: 24666257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of serum squamous cell carcinoma antigen in patients with early cervical squamous cell carcinoma].
    Li D; Xu XX; Yan DD; Yuan SH; Lou HM
    Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):357-362. PubMed ID: 31137169
    [No Abstract]   [Full Text] [Related]  

  • 6. [Outcomes and prognosis of radical surgery in patients with stageⅠb2 and Ⅱa2 cervical squamous cell carcinoma].
    Zhou F; Chen F; Pan T; Zhu T; Zhang YL; Zhang P; Tang HR
    Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):361-369. PubMed ID: 35658327
    [No Abstract]   [Full Text] [Related]  

  • 7. Radiotherapy for Vaginal Recurrences of Cervical Cancer in Patients After Prior Surgery: Analysis of Effect and Prognostic Factors.
    Yan J; Zheng Z; Zhu J; Hu K; Hou X; Shen J; Lian X; Sun S; Miao Z; Shen J; Guan H; Meng Q; Zhang F
    Front Oncol; 2021; 11():744871. PubMed ID: 34589438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic analysis of radiotherapy for cervical lymph node recurrence after curative resection of thoracic esophageal squamous cell carcinoma.
    Chu J; Wang F
    J Radiat Res; 2023 Mar; 64(2):457-462. PubMed ID: 36626680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transperineal low-dose rate iridium-192 interstitial brachytherapy in cervical carcinoma stage IIB.
    Budrukkar AN; Shrivastava SK; Jalali R; Agarwal JP; Deshpande DD; Nehru RM; Dinshaw KA
    Strahlenther Onkol; 2001 Oct; 177(10):517-24. PubMed ID: 11680016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Operable stage IB and II cancer of the uterine neck: retrospective comparison between preoperative utero-vaginal curietherapy and initial surgery followed by radiotherapy].
    Atlan D; Touboul E; Deniaud-Alexandre E; Lefranc JP; Ganansia V; Bernard A; Antoine JM; Jannet D; Lhuillier PE; Uzan M; Genestie C; Antoine M; Jamali M; Milliez J; Uzan S; Blondon J
    Cancer Radiother; 2002 Jun; 6(4):217-37. PubMed ID: 12224488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Operable Stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy.
    Atlan D; Touboul E; Deniaud-Alexandre E; Lefranc JP; Antoine JM; Jannet D; Lhuillier P; Uzan M; Huart J; Genestie C; Antoine M; Jamali M; Ganansia V; Milliez J; Uzan S; Blondon J
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):780-93. PubMed ID: 12377330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
    Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic outcome and prognostic factors in the radiotherapy of recurrences of cervical carcinoma following surgery.
    Hille A; Weiss E; Hess CF
    Strahlenther Onkol; 2003 Nov; 179(11):742-7. PubMed ID: 14605743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of adjuvant radiotherapy on oncological outcomes in patients with early-stage cervical carcinoma with only intermediate-risk factors: a propensity score matching analysis.
    Turkmen O; Kilic F; Tokalioglu AA; Cakir C; Yuksel D; Kilic C; Boran N; Kimyon Comert G; Turan T
    J Obstet Gynaecol; 2022 Oct; 42(7):3204-3211. PubMed ID: 35959796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective study of small-pelvis radiotherapy plus image-guided brachytherapy in stage I-II non-bulky cervical squamous cell carcinoma.
    Yoshimoto Y; Murata K; Irie D; Ando K; Adachi A; Aoki H; Hirakawa T; Noda SE; Nakano T; Ohno T
    J Radiat Res; 2022 Mar; 63(2):290-295. PubMed ID: 35152292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative radiotherapy for uterine cervical cancer: impact of lymph node and histological type on survival.
    Kasuya G; Ogawa K; Iraha S; Nagai Y; Hirakawa M; Toita T; Kakinohana Y; Kudaka W; Inamine M; Ariga T; Aoki Y; Murayama S
    Anticancer Res; 2013 May; 33(5):2199-204. PubMed ID: 23645776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent squamous cell carcinoma of cervix after definitive radiotherapy.
    Hong JH; Tsai CS; Lai CH; Chang TC; Wang CC; Chou HH; Lee SP; Hsueh S
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):249-57. PubMed ID: 15337563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix.
    Kim JS; Kim JS; Kim SY; Kim Ki; Cho MJ
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1247-53. PubMed ID: 12654434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: a multicenter retrospective study (KROG 13-10).
    Noh JM; Park W; Kim YS; Kim JY; Kim HJ; Kim J; Kim JH; Yoon MS; Choi JH; Yoon WS; Kim JY; Huh SJ
    Gynecol Oncol; 2014 Mar; 132(3):618-23. PubMed ID: 24486605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multivariate analysis of para-aortic lymph node recurrence after definitive radiotherapy for stage IB-IVA squamous cell carcinoma of uterine cervix.
    Huang EY; Wang CJ; Chen HC; Fang FM; Huang YJ; Wang CY; Hsu HC
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):834-42. PubMed ID: 18439764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.